2001 Clinical Trials Patients 
Cannabis Law Report
MARCH 23, 2022
However, our drug laws impede research and deny patients access to these highly effective medicines. These disorders include severe depression, anxiety and depression occurring in terminal cancer patients, alcohol and nicotine dependence, and PTSD (post-traumatic stress disorder). Secondly, people report being healed.
Cannabis Law Report
AUGUST 2, 2021
(OTCQB: SPRCY ) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced positive top-line results for its proprietary compound, SCI-160 in a controlled pre-clinical trial on neuropathic and post-operative pain. ” About The Study.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JULY 12, 2019
Access is clearly in demand from Londoners as there is already a waiting list of 150 patients at the London clinic ahead of its opening. Why aren’t more patients in need able to access medicinal cannabis via the NHS, and will this improve? Background to the legalisation of medical cannabis in the UK.
Cannabis Law Report
MARCH 1, 2019
Natalie has worked with private hospitals and clinics in relation to medical malpractice claims, and assisted on cases involving medical devices product liability and clinical trials. But doctors and patients are not only facing administrative or prescribing hurdles – there’s also the cost. Legalisation.
Otherside Farms
JANUARY 23, 2019
cancer cells (full – 2001). Inhibition of Glioma Growth in Vivo by Selective Activation of the CB2 Cannabinoid Receptor1 (full – 2001). full – 2001). Anti-Tumor Effects (news – 2001?). A pilot clinical study of Delta(9)-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme.
CannaMD
AUGUST 26, 2020
Note: No human studies were found (with the exception of one clinical trial that was ongoing and therefore not selected); all studies focused on animals (i.e., Hepatotoxicity , or chemical-driven liver damage, is a serious issue for patients struggling with cocaine addiction. mice/rats).
Cannabis Law Report
JULY 12, 2019
Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. No hepatic side effects were noted.
Expert insights. Personalized for you.
52 
Let's personalize your content